Interestingly, CAR T cell approach has been exploited also against mesothelin, that is expressed in GC tissue, both in vitro and in vivo with favorable results defined by strong cytotoxicity and significant regression of GC subcutaneous masses [211]. This evidence concerns the gene MSLN and gastric cancer.